Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Infographic – Digital Health Venture Funds Remain Stuck

Bar chart: Digital health venture funding worldwide, by quarter

Global venture funding for digital health start-ups remains mired at low levels, as the number of investment deals in the second quarter of 2023 dropped to its lowest level in eight years. . . . → Read More: Infographic – Digital Health Venture Funds Remain Stuck

Cancer Immunotherapy Biotech Issues $80M IPO

Wall Street sign

A biotechnology company designing immunotherapies for solid tumor cancers with a patient’s white blood cells is raising $80 million in its initial public offering or IPO. . . . → Read More: Cancer Immunotherapy Biotech Issues $80M IPO

Infographic – U.S. Life Science Venture Activity Keeps Falling

Bar chart: U.S. life science venture investments by quarter

Investments in life science start-ups in the U.S. show continued declines into the second quarter of 2023, reaching levels not seen in four or five years. . . . → Read More: Infographic – U.S. Life Science Venture Activity Keeps Falling

Venture Fund to Back Life Science A.I. Start-Ups

Synthetic biology

A new venture fund says it’s investing in health and life science start-ups implementing advanced technologies, particularly artificial intelligence, that promise to transform the field. . . . → Read More: Venture Fund to Back Life Science A.I. Start-Ups

Infographic – Venture Funds Continue Slide in Q2

Bar chart: Global venture capital investment dollars by quarter to Q2 2023

Venture capital funding for start-ups worldwide continued dropping in the second quarter of 2023 with dollar volumes down by double digits from just the first quarter of the year. . . . → Read More: Infographic – Venture Funds Continue Slide in Q2

Synthetic DNA Company Gains $10M in Venture Round

Steve Harvey and Derek Stemple in the lab

A company using a process it says can produce synthetic genes with greater accuracy for research and clinical applications is raising $10 million in its first venture round. . . . → Read More: Synthetic DNA Company Gains $10M in Venture Round

Weather Balloon Data Company Raises $6M in Seed Funds

Weather balloon in flight

A company creating a network of long-range high-altitude balloons to expand the scope of global weather forecasting is raising $6 million in seed funds. . . . → Read More: Weather Balloon Data Company Raises $6M in Seed Funds

Biotech Start-Up to Discover Cystic Fibrosis Therapy

Lung x-ray

A new biotechnology company is advancing research to find a comprehensive treatment for cystic fibrosis, and staked to a €2 million seed investment from its founder. . . . → Read More: Biotech Start-Up to Discover Cystic Fibrosis Therapy

Crop Health Device Company Raises $3.5M in Early Funds

Oranges with HLB disease

A company detecting early-stage crop diseases with handheld devices and artificial intelligence is raising $3.5 million in its seed venture round. . . . → Read More: Crop Health Device Company Raises $3.5M in Early Funds

Targeted Genetic Nanoparticle Company Gains $25M in Seed Funds

DNA bubbles illustration

A developer of nanoscale lipid particles for delivering genomic therapies to specific cells and tissue, spun-off from academic labs, is raising $25 million in seed funds. . . . → Read More: Targeted Genetic Nanoparticle Company Gains $25M in Seed Funds